Preliminary studies have indicated that mood stabilisers may be of benefit to people with BPD. Objective: To examine the clinical effectiveness and cost-effectiveness of lamotrigine for people with BPD. Design: A two-arm, double-blind, placebo-controlled individually randomised trial of lamotrigine versus placebo.
(2024) revealed that lamotrigine was not superior to placebo in treating BPD symptoms. Of the 137 participants who received lamotrigine, only 34 (25%) were men
Lamotrigine and BPD/BPD symptoms: Preston et al. (2024) Borderline personality disorder in patients with bipolar disorder and response to lamotrigine.
Borderline Personality Disorder (BPD) Completed Phase 4 Trials for Lamotrigine (DB ) ; NCT , Study of Lamotrigine Treatment of Affective Instability
Be cautious about using mood stabilizers in BPD patients. Lamotrigine can be helpful for affective instability in mild-to-moderate BPD
Be cautious about using mood stabilizers in BPD patients. Lamotrigine can be helpful for affective instability in mild-to-moderate BPD
Lamotrigine versus inert placebo in the treatment of borderline Abstract Background People with borderline personality disorder (BPD)
Today's top videos @bigoumi's videos bpd lamotrigine.
BPD randomized to receive lamotrigine (up to 400 mg/d) or placebo for 52 weeks. At 52 weeks, there was no difference in. ZAN-BPD scores between the lamotrigine.
Comments